Back
Monopar Therapeutics Stock Predictions

Today's Fastest Growing Company Might Surprise You
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
78
MNPR
Monopar Therapeutics
Last Price:
$51.19
Seasonality Move:
-10.68%
7 Day Trial
ALL ACCESS PASS
$
7

BOXABL Announces New $20,000 House
Disclosure: *This is a paid advertisement for Boxabl's Regulation A offering. Please read the offering circular here. This is a message from BoxablMonopar Therapeutics Stock Forecast
-
Over the next 52 weeks, Monopar Therapeutics has on average historically risen by 492.1% based on the past 5 years of stock performance.
-
Monopar Therapeutics has risen higher in 2 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 40%
-
Is Monopar Therapeutics Stock Undervalued?The current Monopar Therapeutics [MNPR] share price is $51.89. The Score for MNPR is 78, which is 56% above its historic median score of 50, and infers lower risk than normal.
-
MNPR is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
Will Monopar Therapeutics Stock Go Up Next Year?
-
Over the next 52 weeks, Monopar Therapeutics has on average historically risen by 492.1% based on the past 5 years of stock performance.
Monopar Therapeutics Stock Rating
Buy
78
Monopar Therapeutics (MNPR)
is a Buy
Is Monopar Therapeutics overpriced?
-
Monopar Therapeutics has risen higher in 2 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 40%
Monopar Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
monopartx.com
52-Week Data
52-Week High:
54.30
52-Week Low:
1.60
Prediction Charts
Market Cap:
273.9M
Price in USD:
51.89
Volume:
103K
Beta:
1.33
Technical Analysis
SMA50:
29.75
SMA100:
20.39
SMA200:
11.84
52-Wk Change:
2865.14%
Stock Predictions
-
Is Monopar Therapeutics stock public?Yes, Monopar Therapeutics is a publicly traded company.
-
What is the Monopar Therapeutics stock quote today?The Monopar Therapeutics stock price is 51.89 USD today.
-
How to buy Monopar Therapeutics stock online?You can buy Monopar Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Jan-22 | 33.76 | 33.67 | 35.00 | 31.95 |
Jan-23 | 33.99 | 39.32 | 39.99 | 33.50 |
Jan-24 | 39.05 | 41.46 | 41.94 | 37.83 |
Jan-27 | 40.55 | 33.52 | 45.27 | 31.00 |
Jan-28 | 34.80 | 41.82 | 42.39 | 34.50 |
Jan-29 | 42.02 | 38.80 | 42.02 | 34.41 |
Jan-30 | 39.50 | 42.50 | 42.50 | 37.20 |
Jan-31 | 42.93 | 43.94 | 44.86 | 38.90 |
Feb-3 | 41.45 | 43.55 | 44.36 | 38.90 |
Feb-4 | 43.50 | 48.00 | 49.98 | 41.83 |
Feb-5 | 48.93 | 48.77 | 51.48 | 45.95 |
Feb-6 | 48.81 | 47.11 | 51.22 | 43.44 |
Feb-7 | 46.16 | 48.46 | 49.22 | 46.16 |
Feb-10 | 48.50 | 51.89 | 54.30 | 47.81 |
Monopar Therapeutics Earnings
Monopar Therapeutics Earnings Report: Per Share Monopar Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Monopar Therapeutics Forecast Revenue Growth
Monopar Therapeutics Stock Analysis: Historical quarterly revenues per share for Monopar Therapeutics and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.50 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.70 per share, and an increase next year of $2.24 per share.
* Monopar Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.